Popular Articles
Natural Remedies

European Medicines Agency Recommends Withdrawal Of Dextropropoxyphene-Containing Medicines (Including Co-Proxamol)
The European Medicines Agency (EMEA) has today announced their recommendation to withdraw the marketing authorisations for dextropropoxyphene-containing medicines (including co-proxamol) across the European Union (EU). This recommendation was made after the Committee on Medicinal Products for Human Use (CHMP) concluded that the risks, particularly of potentially fatal overdose, were greater than the medicine"s benefits. The EMEA"s recommendation has been forwarded to the European Commission (EC) for a decision which will be legally binding across the EU. In the UK, the only medicine affected by the EMEA"s announcement is co-proxamol.
generic viagra online
Changing The EU Public Health Dynamic: Better Science, Regulation And Access Policies To Deliver Biopharmaceutical Innovation For Europe's Citizens
Better science, better regulation and better access policies are needed in Europe to support an
News of the day
UPMC Cardiovascular Institute Recruiting For Severe Coronary Heart Disease Study
The UPMC Cardiovascular Institute currently is enrolling participants for a Phase 2 clinical trial to examine whether administering a naturally occurring protein improves blood supply to the cardiac muscle in patients with severe coronary artery disease.
Medical Devices

Hypoglycemia Increases Mortality Risk, Lengthens Hospital Stay For Diabetes Patients -- Even Outside The ICU

Diabetes patients who are hospitalized for non-critical illnesses, and develop hypoglycemia while hospitalized, are likely to remain hospitalized longer and face greater risk of mortality both during and after hospitalization, according to a study published in the July issue of Diabetes Care. This retrospective cohort study of more than 4,300 admissions, by researchers at Boston"s Brigham and Women"s Hospital, was the first to examine mortality risks for hospitalized diabetes patients outside a critical care setting. Previous research found an association between hypoglycemia in ICU patients and an increased risk of morality, seizures and coma. However, the majority of hospitalized diabetes patients are treated on the general ward. This study found that each hospital day in which a person with diabetes had at least one episode of hypoglycemia was associated with an 85.3 percent increased risk of dying as an inpatient and a 65.8 percent increased risk of dying within one year of discharge. The odds of inpatient death also tripled for every 10 mg/dl decrease in the lowest blood glucose during hospitalization. And, a patient"s length of stay increased by 2.5 days for each day spent in the hospital with a hypoglycemia episode. As a result of these findings, the researchers recommend carefully monitoring people with diabetes admitted to the general ward of the hospital for hypoglycemia and suggest interpreting its appearance as "a warning sign of impending clinical deterioration." "It could serve as a useful indicator for the necessity of increased monitoring, more aggressive treatment of infections, transitioning to a more intensive care setting, and case management," the study concludes. Diabetes Care, published by the American Diabetes Association, is the leading peer-reviewed journal of clinical research into one of the nation"s leading causes of death by disease. Diabetes also is a leading cause of heart disease and stroke, as well as the leading cause of adult blindness, kidney failure, and non-traumatic amputations. The American Diabetes Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):